Maintaining What Is Already There: Strategies to Rectify HSC Transplantation Dilemmas

Cell Stem Cell
Claudia Waskow

Abstract

Hematopoietic stem cell (HSC) transplantation remains the only cure for various hematological diseases, but low HSC numbers in many donor samples are a critical problem preventing their clinical use. Now in Nature and Cell, two creative strategies to rescue and improve pre-existing engraftment potential are presented.

References

Jul 16, 2014·Cell Stem Cell·Kadriye Nehir CosgunClaudia Waskow
Mar 13, 2015·Blood·Susumu GoyamaJames C Mulloy

❮ Previous
Next ❯

Related Concepts

Related Feeds

Blood And Marrow Transplantation

The use of hematopoietic stem cell transplantation or blood and marrow transplantation (bmt) is on the increase worldwide. BMT is used to replace damaged or destroyed bone marrow with healthy bone marrow stem cells. Here is the latest research on bone and marrow transplantation.

Allogenic & Autologous Therapies

Allogenic therapies are generated in large batches from unrelated donor tissues such as bone marrow. In contrast, autologous therapies are manufactures as a single lot from the patient being treated. Here is the latest research on allogenic and autologous therapies.